NCT06723990 2026-02-11
HER2BREASTDX
European Institute of Oncology
Recruiting
Clinical Trials
11 trialsNCT06917313 2026-02-10
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Yale University
Phase 2 Recruiting
NCT07317778 2026-01-05
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06885671 2025-11-17
Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy
British Columbia Cancer Agency
Phase NA Not yet recruiting
NCT07153757 2025-09-04
DESCENT
Fudan University
Phase 3 Not yet recruiting
NCT06765707 2025-07-24
SyMPTOM
Medical College of Wisconsin
Phase NA Enrolling by invitation
NCT06890221 2025-03-26
IPENIPA
University of Malaya
Phase NA Recruiting
NCT06807749 2025-03-24
PERSEVEREX
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT06823414 2025-02-12
Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy
University Hospital A Coruña
Recruiting
NCT06762977 2025-01-08
HERCard
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT06679387 2024-11-07
"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"
Ain Shams University
Phase 2 Recruiting